logo

For the Inventor, By the Inventor

Guangdong, China

Tian Lan

This inventor holds 8 USPTO granted patents and 3 published patent applications. Top assignees: Weixin Technology (Shenzhen) Co., Ltd., Shanghai Zhonghua Pharmaceutical Co., Ltd, Shenzhen Sufeilan Trading Company. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tian Lan. Retrieved from https://idiyas.com/inventor/tian-lan-rnsha991

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 1.1

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Shenzhen, CN (2023)
  • Guangdong, CN (2023 - 2024)

Company Filing History:

goldMedal5 out of 5 
 
Weixin Technology (Shenzhen) Co., Ltd.
 patents
silverMedal1 out of 1 
 
Shanghai Zhonghua Pharmaceutical Co., Ltd
 patent
bronzeMedal1 out of 1 
 
Shenzhen Sufeilan Trading Company
 patent
where one patent can have more than one assignee

Years Active: 2023-2026

Loading Chart...
8 patents (USPTO):Explore Patents
1. D1122658 - Headboard (2026-04-21),
2. D1119390 - Computer desk (2026-03-24),
3. D1118183 - Furniture set (2026-03-17),
4. D1116545 - Electric lifting computer desk (2026-03-10),
5. D1111586 - Storage cabinet with rollaway bed (2026-02-10),
6. D1015028 - Shoe cabinet (2024-02-20),
7. 11793852 - Application of Longhu Rendan in preparing medicament for preventing and/or treating liver fibrosis (2023-10-24),
8. D979958 - Collapsible hanging chair (2023-03-07),

Title: Innovations by Tian Lan in Pharmaceutical Development

Introduction

Tian Lan is a notable inventor based in Guangdong, China, recognized for his contributions to the pharmaceutical industry. He holds two patents that reflect his innovative approach to medicine and health.

Latest Patents

Among his latest patents is a shoe cabinet, which showcases his diverse interests. More significantly, he has developed a medicament for preventing and/or treating liver fibrosis, utilizing Longhu Rendan. This application demonstrates the significant effect of Longhu Rendan in improving fibrosis, with its efficacy in anti-liver fibrosis and liver protection being comparable to that of the positive drug silybin.

Career Highlights

Tian Lan is associated with Shanghai Zhonghua Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical research and development. His work has contributed to advancements in treatments for liver conditions, showcasing his commitment to improving patient health.

Collaborations

He collaborates with talented coworkers, including Jiahua Jin and Biye Wang, who contribute to his innovative projects and research endeavors.

Conclusion

Tian Lan's work exemplifies the intersection of innovation and healthcare, particularly in the development of effective treatments for liver fibrosis. His contributions are significant in advancing pharmaceutical science and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…